Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

11
results for

"In Hee Kim"

Article category

Keywords

Publication year

"In Hee Kim"

Original Article

Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial
Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, Won Kim, Young Kul Jung, Jae Young Jang, Sae Hwan Lee, Yun Soo Kim, Chang Wook Kim, Hyoung Su Kim, Jae-Jun Shim, Eun-Young Cho, In Hee Kim, Byung Seok Lee, Jeong-Hoon Lee, Byung Seok Kim, Jeong Won Jang, Hyun Woong Lee, Jung Hyun Kwon, Moon Young Kim, Do Seon Song, Jung Gil Park, Yoon Seok Lee, Eileen L. Yoon, Han Ah Lee, Seong Hee Kang, Jin Mo Yang
Clin Mol Hepatol 2025;31(3):810-822.
Published online January 17, 2025
DOI: https://doi.org/10.3350/cmh.2024.0819
Background/Aims
Besifovir (BSV) showed comparable antiviral activity and superior safety profiles to tenofovir disoproxil fumarate (TDF) in treatment-naïve chronic hepatitis B (CHB). However, no data are available regarding the antiviral efficacy and safety of BSV in patients with CHB who switched from long-term TDF to BSV. This study aimed to evaluate the outcome of a 48-week BSV therapy in patients with CHB who switched from long-term TDF treatment.
Methods
In this non-inferiority trial, 153 CHB patients treated with TDF for ≥48 weeks who had hepatitis B virus (HBV) DNA <20 IU/mL were randomized to receive either BSV 150 mg or TDF 300 mg for 48 weeks.
Results
The per-protocol analysis included 130 patients (BSV group, 64; TDF group, 66). The median duration of TDF use before enrollment was 4.14 years. After 48 weeks, 100.0% and 98.5% patients in the BSV and TDF groups, respectively, met the primary endpoint (HBV DNA <20 IU/mL), demonstrating the non-inferior antiviral efficacy of BSV to TDF (95% confidence interval –0.01 to 0.04; P>0.999), with a predefined margin of –0.18. The mean percentage changes in estimated glomerular filtration rates were slightly better in the BSV group (1.67±11.73%) than in the TDF group (–1.24±11.02%). The BSV group showed a significant improvement in bone turnover biomarkers compared to the TDF group; accordingly, hip and spine bone mineral density increased in the BSV group.
Conclusions
In patients with CHB receiving long-term TDF, switching to BSV may improve renal and bone safety with non-inferior antiviral efficacy compared to that of maintaining TDF.

Citations

Citations to this article as recorded by  Crossref logo
  • Correspondence to editorial on “Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial”
    Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Jin Mo Yang
    Clinical and Molecular Hepatology.2026; 32(1): e55.     CrossRef
  • Besifovir: a viable option for long-term disease control in chronic hepatitis B: Editorial on “Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial”
    Wai-Kay Seto
    Clinical and Molecular Hepatology.2026; 32(1): 374.     CrossRef
  • Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch
    Zhi-Hao Zeng, Jin-Qing Liu, Min Zhang, Cai-Liang Qiu, Zhen-Yu Xu
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • 10,503 View
  • 169 Download
  • Crossref

Correspondences

Viral hepatitis

Correspondence to letter to the editor on “Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults”
Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
Clin Mol Hepatol 2025;31(2):e149-e151.
Published online November 6, 2024
DOI: https://doi.org/10.3350/cmh.2024.0944
  • 5,764 View
  • 26 Download

Viral hepatitis

  • 5,097 View
  • 55 Download

Original Article

Viral hepatitis

Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, Sojung Han, Eun Sun Jang, Young Eun Chon, Young Chang, Kyung-Ah Kim, Do Young Kim, Hyung Joon Yim, Hye-Lin Kim, Sook-Hyang Jeong, In Hee Kim
Clin Mol Hepatol 2023;29(3):779-793.
Published online May 15, 2023
DOI: https://doi.org/10.3350/cmh.2023.0110
Background/Aims
To eliminate hepatitis B virus (HBV) and hepatitis C virus (HCV) according to the World Health Organization (WHO) criteria in 2021, this study investigated the national core indicators representing the current status of viral hepatitis B and C in South Korea.
Methods
We analyzed the incidence, linkage-to-care, treatment, and mortality rates of HBV and HCV infection using the integrated nationwide big data of South Korea.
Results
According to data from 2018–2020, the incidence of acute HBV infection in South Korea was 0.71 cases per 100,000 population; tthe linkage-to-care rate was only 39.4%. Among those who need hepatitis B treatment, the treatment rate was 67.3%, which was less than 80% reported in the WHO program index. The annual liver-related mortality due to HBV was 18.85 cases per 100,000 population, exceeding the WHO target of four; the most frequent cause of death was liver cancer (54.1%). The annual incidence of newly diagnosed HCV infection was 11.9 cases per 100,000 population, which was higher than the WHO impact target of five. Among HCV-infected patients, the linkage-to-care rate was 65.5% while the treatment rate was 56.8%, which were below the targets of 90% and 80%, respectively. The liver-related annual mortality rate due to HCV infection was 2.02 cases per 100,000 population.
Conclusions
Many of the current indicators identified in the Korean population did not satisfy the WHO criteria for validation of viral hepatitis elimination. Hence, a comprehensive national strategy should be urgently developed with continuous monitoring of the targets in South Korea.

Citations

Citations to this article as recorded by  Crossref logo
  • Implementation of an alert system for the care cascade of Hepatitis C infection in patients undergoing elective surgery
    Jae Seung Lee, Ho Soo Chun, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
    Journal of Infection and Public Health.2026; 19(2): 103076.     CrossRef
  • AI-Safe-C score: Assessing liver-related event risks in patients without cirrhosis after successful direct-acting antiviral treatment
    Huapeng Lin, Terry Cheuk-Fung Yip, Hye Won Lee, Xiangjun Meng, Jimmy Che-To Lai, Sang Hoon Ahn, Wenjing Pang, Grace Lai-Hung Wong, Lingfeng Zeng, Vincent Wai-Sun Wong, Victor de Lédinghen, Seung Up Kim
    Journal of Hepatology.2025; 82(3): 456.     CrossRef
  • Burden, trends, and predictions of liver cancer in China, Japan, and South Korea: analysis based on the Global Burden of Disease Study 2021
    Si Yang, Yujiao Deng, Yi Zheng, Jing Zhang, Dongdong He, Zhijun Dai, Changcun Guo
    Hepatology International.2025; 19(2): 441.     CrossRef
  • Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults
    Donghee Kim, Won Kim, Aijaz Ahmed
    Clinical and Molecular Hepatology.2025; 31(1): e5.     CrossRef
  • Etiologic, epidemic, medical and economic aspects of hepatocellular carcinoma
    N. A. Vlasova, V. I. Apanasevich, E. V. Eliseeva, S. S. Startsev
    Сибирский научный медицинский журнал.2025; 45(1): 6.     CrossRef
  • HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on “Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of dis
    Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, Hankil Lee, Sang Hoon Ahn
    Clinical and Molecular Hepatology.2025; 31(2): e163.     CrossRef
  • Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea: Editorial on “Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiven
    Eun Sun Jang
    Clinical and Molecular Hepatology.2025; 31(2): 596.     CrossRef
  • Temporal and geospatial patterns of hepatitis C virus prevalence: a longitudinal examination using national health insurance service data in the Republic of Korea (2005–2022)
    Hwa Young Choi, Moran Ki
    BMC Public Health.2025;[Epub]     CrossRef
  • Correspondence to letter to the editor on “Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults”
    Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
    Clinical and Molecular Hepatology.2025; 31(2): e149.     CrossRef
  • Incidence of Osteopenia or Osteoporosis in Asian Patients With Chronic Hepatitis B
    Hye Won Lee, Sungshin Kwon, Yeo Rae Moon, Hyunjung Ahn, Juyeon Lee, Sang‐Hoon Ahn
    Journal of Gastroenterology and Hepatology.2025; 40(6): 1586.     CrossRef
  • A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles
    Lindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, Maria Buti, Loreta A Kondili, C Wendy Spearman, Nishi Prabdial-Sing, Victoria Turnier, Jeffrey V Lazarus, Imam Waked, John W Ward, Angelica Miranda, Aya Sugiyama, Behzad Hajarizadeh, Carlos Varaldo, Ca
    The Lancet Gastroenterology & Hepatology.2025; 10(7): 671.     CrossRef
  • Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysis
    Alexander J Stockdale, Bethany Holt, Ajeet Singh Bhadoria, Abhishek Sadasivan, Daniel Ikeda, Todd Pollack, Janus P Ong, Thuy Pham, David B Duong, Vy Nguyen, Gibril Ndow, Roger Chou, Philippa Easterbrook
    The Lancet Gastroenterology & Hepatology.2025; 10(11): 1013.     CrossRef
  • Prevalence, Clinical Characteristics, and Treatment Status of Hepatitis C Virus Infection among People Who Use Drugs in South Korea: A Prospective Multicenter Study
    Gwang Hyeon Choi, Young-Hoon Chon, Do Hoon Kwon, Sung Nam Jo, Og-Jin Jang, Kyung-Ah Kim, Dahye Baik, Eun Sun Jang, Sook-Hyang Jeong
    Gut and Liver.2025; 19(5): 725.     CrossRef
  • Etiological, Epidemiological, and Medical-Economic Aspects of Hepatocellular Carcinoma (A Review)
    N. A. Vlasova, V. I. Apanasevich, E. V. Eliseeva, S. S. Startsev
    Cell and Tissue Biology.2025; 19(6): 525.     CrossRef
  • Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees: a Delphi-based study
    Domenico Pascucci, Aina Nicolàs, Abdelrahman Taha, Jeffrey V Lazarus, Matteo Di Pumpo, Vittoria Tricomi, Francesco Di Berardino, Carlo La Vecchia, José A Perez-Molina, Giuseppe Colucci, Camila A Picchio, Angelo Maria Pezzullo, Stefania Boccia
    Journal of Global Health.2025;[Epub]     CrossRef
  • Disease burden of chronic hepatitis B and C patients in South Korea: a population-based 16-year cohort study
    Oeuk Jeong, Changhee Chu, Jungyeon Kim, Jae Seung Lee, Jun Yong Park, Kyung Eun Lee, Jaehyun Seong, Min Jin Go
    BMC Infectious Diseases.2025;[Epub]     CrossRef
  • Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007–2021: a nationwide, multicentre, retrospective cohort study
    Won Sohn, Soo Young Park, Tae Hee Lee, Young Eun Chon, In Hee Kim, Byung-Seok Lee, Ki Tae Yoon, Jae Young Jang, Yu Rim Lee, Su Jong Yu, Won-Mook Choi, Sang Gyune Kim, Dae Won Jun, Joonho Jeong, Ji Hoon Kim, Eun Sun Jang, Hwi Young Kim, Sung Bum Cho, Byoun
    eClinicalMedicine.2024; 73: 102671.     CrossRef
  • Linvencovir: Paving the way for functional cure in hepatitis B
    Jiwon Yang, Jonggi Choi
    Clinical and Molecular Hepatology.2024; 30(2): 164.     CrossRef
  • Higher FIB-4 index at baseline predicts development of liver cancer in a community-based cohort with viral hepatitis
    Makiko Kimura, Tomoki Nishikawa, Tetsuro Shimakami, Takeshi Terashima, Rika Horii, Masako Fukuda, Mika Yoshita, Noboru Takata, Tomoyuki Hayashi, Masaya Funaki, Kouki Nio, Hajime Takatori, Kuniaki Arai, Tatsuya Yamashita, Masao Honda, Junko Tanaka, Shuichi
    Global Health & Medicine.2024; 6(6): 404.     CrossRef
  • Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease
    Marta Belka, Aleksandra Gostyńska-Stawna, Maciej Stawny, Violetta Krajka-Kuźniak
    International Journal of Molecular Sciences.2024; 25(20): 11213.     CrossRef
  • Correspondence to editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”
    Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
    Clinical and Molecular Hepatology.2024; 30(4): 997.     CrossRef
  • Elimination of viral hepatitis: How far are we?: Editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”
    Eun Ju Cho
    Clinical and Molecular Hepatology.2024; 30(4): 663.     CrossRef
  • 9,474 View
  • 222 Download
  • 20 Web of Science
  • Crossref

Erratum

Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509]
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Seok Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
Clin Mol Hepatol 2023;29(3):830-830.
Published online April 13, 2023
DOI: https://doi.org/10.3350/cmh.2022.0345e
Corrects: Clin Mol Hepatol 2023;29(2):496
  • 5,331 View
  • 32 Download

Original Articles

Viral hepatitis

Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
Clin Mol Hepatol 2023;29(2):496-509.
Published online March 6, 2023
DOI: https://doi.org/10.3350/cmh.2022.0345
Background/Aims
We used next-generation sequencing (NGS) to analyze resistance-associated substitutions (RASs) and retreatment outcomes in patients with chronic hepatitis C virus (HCV) infection who failed direct-acting antiviral agent (DAA) treatment in South Korea.
Methods
Using prospectively collected data from the Korean HCV cohort study, we recruited 36 patients who failed DAA treatment in 10 centers between 2007 and 2020; 29 blood samples were available from 24 patients. RASs were analyzed using NGS.
Results
RASs were analyzed for 13 patients with genotype 1b, 10 with genotype 2, and one with genotype 3a. The unsuccessful DAA regimens were daclatasvir+asunaprevir (n=11), sofosbuvir+ribavirin (n=9), ledipasvir/sofosbuvir (n=3), and glecaprevir/pibrentasvir (n=1). In the patients with genotype 1b, NS3, NS5A, and NS5B RASs were detected in eight, seven, and seven of 10 patients at baseline and in four, six, and two of six patients after DAA failure, respectively. Among the 10 patients with genotype 2, the only baseline RAS was NS3 Y56F, which was detected in one patient. NS5A F28C was detected after DAA failure in a patient with genotype 2 infection who was erroneously treated with daclatasvir+asunaprevir. After retreatment, 16 patients had a 100% sustained virological response rate.
Conclusions
NS3 and NS5A RASs were commonly present at baseline, and there was an increasing trend of NS5A RASs after failed DAA treatment in genotype 1b. However, RASs were rarely present in patients with genotype 2 who were treated with sofosbuvir+ribavirin. Despite baseline or treatment-emergent RASs, retreatment with pan-genotypic DAA was highly successful in Korea, so we encourage active retreatment after unsuccessful DAA treatment.

Citations

Citations to this article as recorded by  Crossref logo
  • Precision oncology through next generation sequencing in hepatocellular carcinoma
    Sayali Shinde, Carola Maria Bigogno, Ana Simmons, Nikita Kathuria, Aruni Ghose, Vedika Apte, Patricia Lapitan, Shania Makker, Aydin Caglayan, Stergios Boussios
    Heliyon.2025; 11(3): e42054.     CrossRef
  • Bridging the Gap in Elimination of Hepatitis C Virus among People Who Use Drugs in South Korea
    Beom Kyung Kim
    Gut and Liver.2025; 19(5): 635.     CrossRef
  • Correspondence on Letter regarding “Toward hepatitis C virus elimination using artificial intelligence”
    Ming-Ying Lu, Ming-Lung Yu
    Clinical and Molecular Hepatology.2024; 30(2): 274.     CrossRef
  • 8,591 View
  • 176 Download
  • 3 Web of Science
  • Crossref

Viral hepatitis

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn
Clin Mol Hepatol 2020;26(3):352-363.
Published online May 28, 2020
DOI: https://doi.org/10.3350/cmh.2019.0044n
Background/Aims
Suboptimal responses to lamivudine or telbivudine plus adefovir (LAM/LdT+ADV) rescue therapy are common in patients with LAM-resistant hepatitis B virus (HBV) infections. We compared patients switched to entecavir plus tenofovir (ETV+TDF) to those maintained on LAM/LdT+ADV.
Methods
This prospective randomized controlled trial examined 91 patients whose serum HBV DNA levels were greater than 60 IU/mL after at least 24 weeks of treatment with LAM/LdT+ADV for LAM-resistant HBV. Patients were randomized to receive a new treatment (ETV+TDF, n=45) or maintained on the same treatment (LAM/LdT+ADV, n=46) for 48 weeks. Patients with baseline ADV resistance were excluded.
Results
Compared to LAM/LdT+ADV group, ETV+TDF group had more patients with a virologic response (42/45 [93.33%] vs. 3/46 [6.52%], P<0.001) and had a greater mean reduction in serum HBV DNA level from baseline (-4.16 vs. -0.37 log10 IU/mL, P<0.001). Multivariate analysis indicated that high baseline HBV DNA level (P=0.005) and LAM/LdT+ADV maintenance therapy (P=0.001) were negatively associated with virologic response. At week 48, additional ADV- or ETV-associated mutations were cleared in ETV+TDF group, but such mutations were present in 4.3% of patients in LAM/LdT+ADV group (P=0.106). The two groups had similar rates of adverse events.
Conclusions
ETV+TDF combination treatment led to a significantly higher rate of virologic response compared to LAM/LdT+ADV combination treatment in patients with LAM-resistant HBV who had suboptimal responses to LAM/LdT+ADV regardless of HBV genotypic resistance profile (NCT01597934).

Citations

Citations to this article as recorded by  Crossref logo
  • Research Status of Antiviral Therapy for Chronic Hepatitis B
    漫 赵
    Advances in Clinical Medicine.2025; 15(04): 1194.     CrossRef
  • Viral oncogenesis in cancer: from mechanisms to therapeutics
    Qing Xiao, Yi Liu, Tingting Li, Chaoyu Wang, Sanxiu He, Liuyue Zhai, Zailin Yang, Xiaomei Zhang, Yongzhong Wu, Yao Liu
    Signal Transduction and Targeted Therapy.2025;[Epub]     CrossRef
  • High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana
    Bonolo B. Phinius, Motswedi Anderson, Irene Gobe, Margaret Mokomane, Wonderful T. Choga, Basetsana Phakedi, Tsholofelo Ratsoma, Gorata Mpebe, Joseph Makhema, Roger Shapiro, Shahin Lockman, Rosemary Musonda, Sikhulile Moyo, Simani Gaseitsiwe
    Viruses.2024; 16(4): 592.     CrossRef
  • Real-world study on the efficacy and safety of different treatment regimens in treatment-naïve CHB patients with high viral load
    Xue Wu, Qin Yan, Chunmei Jiang, Rongshan Fan, Sheling Li
    Scientific Reports.2024;[Epub]     CrossRef
  • Target-centric analysis of hepatitis B: identifying key molecules and pathways for treatment
    Xinyu Song, Jinlu Zhu, Fengzhi Sun, Nonghan Wang, Xiao Qiu, Qingjun Zhu, Jianhong Qi, Xiaolong Wang
    Scientific Reports.2024;[Epub]     CrossRef
  • Exploring the impact of hepatitis B immunoglobulin and antiviral interventions to reduce vertical transmission of hepatitis B virus
    Dhita Prabasari Wibowo, Agustiningsih Agustiningsih, Sri Jayanti, Caecilia H C Sukowati, Korri Elvanita El Khobar
    World Journal of Experimental Medicine.2024;[Epub]     CrossRef
  • Bictegravir/Emtricitabine/Tenofovir Alafenomide for the Treatment of HIV/Hepatitis B Virus Co-infection in Patients with Cancer and Transplant Recipients
    Jana K Dickter, Justine A Ross
    Infectious Diseases.2023; 2(1): 31.     CrossRef
  • Old age as a risk factor for liver diseases: Modern therapeutic approaches
    Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva
    Experimental Gerontology.2023; 184: 112334.     CrossRef
  • Study on the intestinal permeability of lamivudine using Caco-2 cells monolayer and Single-pass intestinal perfusion
    Weiyin Huang, Shuang Chen, Lin Sun, Hubin Wwang, Hongqun Qiao
    Saudi Journal of Biological Sciences.2022; 29(4): 2247.     CrossRef
  • External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
    Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Cancers.2022; 14(3): 711.     CrossRef
  • 8,628 View
  • 205 Download
  • 7 Web of Science
  • Crossref

Liver Imaging

Hepatic neoplasm

Recent advances in the imaging of hepatocellular carcinoma
Myung-Won You, So Yeon Kim, Kyoung Won Kim, So Jung Lee, Yong Moon Shin, Jin Hee Kim, Moon-Gyu Lee
Clin Mol Hepatol 2015;21(1):95-103.
Published online March 25, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.1.95

The role of imaging is crucial for the surveillance, diagnosis, staging and treatment monitoring of hepatocellular carcinoma (HCC). Over the past few years, considerable technical advances were made in imaging of HCCs. New imaging technology, however, has introduced new challenges in our clinical practice. In this article, the current status of clinical imaging techniques for HCC is addressed. The diagnostic performance of imaging techniques in the context of recent clinical guidelines is also presented.

Citations

Citations to this article as recorded by  Crossref logo
  • PEGylated gas vesicles: a promising novel ultrasound contrast agent for diagnosis and guiding radiofrequency ablation of liver tumor
    Kezhi Yu, Yongquan Huang, Yuanyuan Wang, Qunyan Wu, Zihang Wang, Fei Li, Jianri Chen, Maierhaba Yibulayin, Shushan Zhang, Zhongzhen Su, Fei Yan
    Journal of Nanobiotechnology.2025;[Epub]     CrossRef
  • Tumor‐Targeted FABP5/STING Cascade Promote Radiofrequency Ablation Induced Ferroptosis and Intratumoral Immune Rewiring in Hepatocellular Carcinoma
    Bufu Tang, Xiaojie Zhang, Yiting Sun, Jinhua Luo, Qiaoyou Weng, Cong Zhang, Zilin Wang, Shiji Fang, Yangrui Xiao, Liyun Zheng, Jianfei Tu, Rongfang Qiu, Yang Yang, Zhongwei Zhao, Weiqian Chen, Minjiang Chen, Jiansong Ji
    Advanced Science.2025;[Epub]     CrossRef
  • Trends of liver cell carcinoma mortality in the United States by demographics and geography
    Sishir Doddi, Oscar Salichs, Taryn Hibshman, Puneet Bhargava
    Current Problems in Diagnostic Radiology.2024; 53(2): 208.     CrossRef
  • Synthesis of Ultrasmall Fe3O4 Nanoparticles as T1–T2 Dual-Modal Magnetic Resonance Imaging Contrast Agents in Rabbit Hepatic Tumors
    Chen Bai, Pengcheng Hu, Nianlong Liu, Guodong Feng, Di Liu, Yi Chen, Ming Ma, Ning Gu, Yu Zhang
    ACS Applied Nano Materials.2020; 3(4): 3585.     CrossRef
  • Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System
    Sonal Krishan, Radha K. Dhiman, Navin Kalra, Raju Sharma, Sanjay S. Baijal, Anil Arora, Ajay Gulati, Anu Eapan, Ashish Verma, Shyam Keshava, Amar Mukund, S. Deva, Ravi Chaudhary, Karthick Ganesan, Sunil Taneja, Ujjwal Gorsi, Shivanand Gamanagatti, Kumble
    Journal of Clinical and Experimental Hepatology.2019; 9(5): 625.     CrossRef
  • Highly Sensitive Diagnosis of Small Hepatocellular Carcinoma Using pH-Responsive Iron Oxide Nanocluster Assemblies
    Jingxiong Lu, Jihong Sun, Fangyuan Li, Jin Wang, Jianan Liu, Dokyoon Kim, Chunhai Fan, Taeghwan Hyeon, Daishun Ling
    Journal of the American Chemical Society.2018; 140(32): 10071.     CrossRef
  • Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesions
    Dietmar Tamandl, Ahmed Ba-Ssalamah, Gernot Böhm, Klaus Emmanuel, Rosemarie Forstner, Reinhold Függer, Benjamin Henninger, Oliver Koch, Claus Kölblinger, Hans-Jörg Mischinger, Wolfgang Schima, Helmut Schöllnast, Stefan Stättner, Klaus Kaczirek
    Wiener klinische Wochenschrift.2018; 130(21-22): 665.     CrossRef
  • Potential ultrastructure predicting factors for hepatocellular carcinoma in HCV infected patients
    Soheir S. Mansy, Eman El-Ahwany, Soheir Mahmoud, Sara Hassan, Mohammed I. Seleem, Amr Abdelaal, Ahmed H. Helmy, Mona K. Zoheiry, Ahmed S. AbdelFattah, Moataz H. Hassanein
    Ultrastructural Pathology.2017; 41(3): 209.     CrossRef
  • Liver resection for intermediate hepatocellular carcinoma
    Peng-Sheng Yi, Ming Zhang, Ji-Tong Zhao, Ming-Qing Xu
    World Journal of Hepatology.2016; 8(14): 607.     CrossRef
  • 14,094 View
  • 128 Download
  • 9 Web of Science
  • Crossref

Original Article

Viral hepatitis

Geographic differences in the epidemiological features of HCV infection in Korea
Kyung-Ah Kim, Sook-Hyang Jeong, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, Eun Uk Jung, In Hee Kim, Sung Bum Cho, Mee-Kyung Kee, Chun Kang
Clin Mol Hepatol 2014;20(4):361-367.
Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.361
Background/Aims

The prevalence of hepatitis C virus (HCV) infection in Korea exhibits significant geographic variation, with it being higher in Busan and Jeonam than in other areas. The reason for this intranational geographic difference was investigated in this study by conducting a comparative analysis of the risk factors related to HCV infection among three geographic areas: the capital (Seoul), Busan, and the province of Jeolla.

Methods

In total, 990 patients with chronic HCV infection were prospectively enrolled at 5 university hospitals located in Seoul (n=374), Busan (n=264), and Jeolla (n=352). A standardized questionnaire survey on the risk factors for HCV infection was administered to these three groups of patients, and a comparative analysis of the findings was performed.

Results

The analysis revealed significant regional differences in exposure to the risk factors of HCV infection. By comparison with patients in Seoul as a control group in the multivariate analysis, patients in Busan had significantly more experience of invasive medical procedures, acupuncture, cosmetic procedures, and multiple sex partners. In contrast, patients in Jeolla were significantly older, and they had a higher prevalence of hepatocellular carcinoma, a lower prevalence of multiple sex partners, and had experienced fewer invasive procedures.

Conclusions

There was a significant geographic difference in the exposure to potential risk factors of HCV infection between patients from the three studied regions. This may explain the regional variation of the prevalence of HCV infection in Korea, and should be taken into account when planning strategies for the prevention and management of HCV infection.

Citations

Citations to this article as recorded by  Crossref logo
  • 부산광역시, 울산광역시, 경상남도 지역의 C형간염 발생 현황 및 특성, 2018-2023년
    선태 김, 지은 엄, 혁진 이, 유진 조, 슬기 강, 동한 이, 상은 이
    Public Health Weekly Report.2025; 18(6): 277.     CrossRef
  • 호남권 시도·시군구 단위의 C형간염 발생률 및 추이 분석, 2017-2021년
    영숙 최, 상용 엄, 정희 유
    Public Health Weekly Report.2023; 16(24): 743.     CrossRef
  • Epidemiology and treatment status of hepatitis C virus infection among people who have ever injected drugs in Korea: a prospective multicenter cohort study from 2007 to 2019 in comparison with non-PWID
    Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, In Hee Kim, Sung Bum Cho, Moran Ki, Hwa Young Choi, Dahye Paik, Sook-Hyang Jeong
    Epidemiology and Health.2021; 43: e2021077.     CrossRef
  • Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination Survey
    Kyung-Ah Kim, June Sung Lee
    Gut and Liver.2020; 14(5): 644.     CrossRef
  • Sofosbuvir plus ribavirin for the treatment of hepatitis C virus genotype 2 in Korea: What's the optimal dosage of ribavirin in real‐world setting?
    Jae Hyun Yoon, Chung Hwan Jun, Ji Ho Seo, Hyun A Cho, Sung Bum Cho, Sung Kyu Choi, Ju Yeon Cho, Man Woo Kim, Sung Wook Lim
    Journal of Digestive Diseases.2019; 20(1): 31.     CrossRef
  • A large healthcare-associated outbreak of hepatitis C virus genotype 1a in a clinic in Korea
    Yoon-Seok Chung, Ju-yeon Choi, Myung Guk Han, Kye Ryeong Park, Su-Jin Park, Hyerim Lee, Youngmee Jee, Chun Kang
    Journal of Clinical Virology.2018; 106: 53.     CrossRef
  • Seropositivity of Hepatitis C Virus among Persons affected Leprosy in Korea
    Jong-Pill Kim, Kuk-Hyeong Kang, Jin-Mo Park
    Korean Leprosy Bulletin.2018; 51(1): 13.     CrossRef
  • KASL clinical practice guidelines: management of hepatitis C

    Clinical and Molecular Hepatology.2016; 22(1): 76.     CrossRef
  • Recent outbreaks of hepatitis C virus infection in Korea and strategy for prevention
    In Hee Kim
    Journal of the Korean Medical Association.2016; 59(12): 912.     CrossRef
  • Recent outbreaks of hepatitis C virus infection in Korea and strategy for prevention
    In Hee Kim
    Journal of the Korean Medical Association.2016; 59(12): 912.     CrossRef
  • Clinical Characteristics of Defectors from North Korea Visiting a Single Tertiary Hospital in South Korea
    Sun Young Ann, Sung Hyeok Ryou, Suk Bae Kim
    Korean Journal of Medicine.2015; 89(1): 54.     CrossRef
  • Epidemiology of Hepatitis C Virus Infection in Korea
    Sook-Hyang Jeong
    Korean Journal of Medicine.2015; 88(6): 630.     CrossRef
  • 10,334 View
  • 64 Download
  • 6 Web of Science
  • Crossref

Review

Revision and update on clinical practice guideline for liver cirrhosis
Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang
Korean J Hepatol 2012;18(1):1-21.
Published online March 22, 2012
DOI: https://doi.org/10.3350/kjhep.2012.18.1.1

Citations

Citations to this article as recorded by  Crossref logo
  • GLOBE Score and UK‐PBC Risk Score Predict Long‐Term Clinical Outcomes of Patients With Primary Biliary Cholangitis and Receiving Ursodeoxycholic Acid and Fenofibrate
    Shu Xiang Li, Bu Er Li, Min Li, Sha Chen, Ting Ting Lyu, Qian Yi Wang, Xiao Ming Wang, Yu Wang, Hong Ma, Xiao Juan Ou, Yuan Yuan Kong, Xin Yan Zhao, Hong You, Wei Jia Duan, Ji Dong Jia
    Journal of Digestive Diseases.2025; 26(5-6): 250.     CrossRef
  • Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
    Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
    Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
  • MetaLAB‐HOI: Template standardization of health outcomes enable massive and accurate detection of adverse drug reactions from electronic health records
    Suehyun Lee, Hyunah Shin, Seon Choe, Min‐Gyu Kang, Sae‐Hoon Kim, Dong Yoon Kang, Ju Han Kim
    Pharmacoepidemiology and Drug Safety.2024;[Epub]     CrossRef
  • Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena
    Mengqi Li, Sha Chen, Shuxiang Li, Tingting Lv, Buer Li, Shan Shan, Min Li, Na Zeng, Qianyi Wang, Yuanyuan Kong, Hong Ma, Xinyan Zhao, Xiaojuan Ou, Hong You, Weijia Duan, Jidong Jia
    Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
  • Establishment and evaluation of an early prediction model of hepatorenal syndrome in patients with decompensated hepatitis B cirrhosis
    Shouhao Wang, Zhewen Zhou, Chengan Xu, Hanzhu Chen, Wenya Ren, Xingdi Yang, Qiaoqiao Yin, Wei Zheng, Hongying Pan
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Initial treatment response and short-term mortality of spontaneous bacterial peritonitis in cirrhotic patients with hepatocellular carcinoma
    Chang Hun Lee, Hye Jin Kang, Song Yi Yu, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • The Wnt/β-catenin signaling pathway plays a role in drug-induced liver injury by regulating cytochrome P450 2E1 expression
    Yoo-Sub Shin, Da-Bin Hwang, Dong-Hoon Won, Shin-Young Kim, Changuk Kim, Jun Won Park, Young Jeon, Jun-Won Yun
    Toxicological Research.2023; 39(3): 443.     CrossRef
  • Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study
    Jae-Hyun Yoon, Sung-Eun Kim, Su-Hyeon Cho, Gi-Ae Kim, Yewan Park, Ji-Won Park, Seong-Hee Kang, Young-Sun Lee, Jeong-Han Kim
    Medicina.2023; 59(8): 1436.     CrossRef
  • Concomitant gallstone disease was not associated with long‐term outcomes in ursodeoxycholic acid‐treated patients with primary biliary cholangitis
    Sha Chen, Meng Qi Li, Bu Er Li, Ting Ting Lv, Shu Xiang Li, Shan Shan, Min Li, Yuan Yuan Kong, Dong Zhang, Hong Ma, Xiao Juan Ou, Hong You, Wei Jia Duan, Ji Dong Jia
    Journal of Digestive Diseases.2023; 24(6-7): 419.     CrossRef
  • Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis
    Sha Chen, Tingting Lv, Guangyong Sun, Shuxiang Li, Weijia Duan, Chunpan Zhang, Hua Jin, Dan Tian, Mingyang Li, Shan Shan, Hong Ma, Xiaojuan Ou, Hong You, Dong Zhang, Jidong Jia
    Hepatology International.2022; 16(1): 195.     CrossRef
  • KASL clinical practice guidelines for management of chronic hepatitis B

    Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
  • Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration
    Jung Hee Kim, Sung-Eun Kim, Do-Seon Song, Hee-Yeon Kim, Eileen Yoon, Tae-Hyung Kim, Young-Kul Jung, Ki Tae Suk, Baek-Gyu Jun, Hyung-Joon Yim, Jung-Hyun Kwon, Sung-Won Lee, Seong-Hee Kang, Moon-Young Kim, Soung-Won Jeong, Jae-Young Jang, Jeong-Ju Yoo, Sang
    Journal of Clinical Medicine.2022; 11(9): 2463.     CrossRef
  • Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis
    Sha Chen, Meng-Qi Li, Wei-Jia Duan, Bu-Er Li, Shu-Xiang Li, Ting-Ting Lv, Lin Ma, Ji-Dong Jia
    Hepatobiliary & Pancreatic Diseases International.2022; 21(6): 577.     CrossRef
  • Expression Patterns of Tumor Markers in Liver Transplant Recipients Showing Complete Pathological Response of Hepatocellular Carcinoma
    Min-Jae Kim, Woo-Hyoung Kang, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park
    Journal of Clinical Medicine.2022; 11(19): 5897.     CrossRef
  • First experience of liver transplantation for HIV-positive patients in Russia
    M. S. Novruzbekov, V. A. Gulyaev, A. I. Mazus, E. V. Ivannikov, M. S. Yadrikhinskaya, K. N. Lutsyk, O. D. Olisov, R. B. Akhmetshin, K. M. Magomedov, B. I. Kazymov, A. R. Akhmedov, K. F. Alekberov, B. I. Yaremin
    Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2022; 12(6): 139.     CrossRef
  • Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
    Hye Yeon Chon, Jae Seung Lee, Hye Won Lee, Ho Soo Chun, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
    Hepatology Research.2021; 51(4): 406.     CrossRef
  • Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites
    Jin Wook Lee, Jae Seok Hwang, Woo Jin Chung, Heon Ju Lee, Jung Gil Park, Chang Hyeong Lee, Byung Seok Kim, Jeong Eun Song, Young Oh Kweon, Won Young Tak, Soo Young Park, Se Young Jang, Jeong Ill Suh, Byoung Kuk Jang, Bhagwan Dass
    PLOS ONE.2021; 16(6): e0253886.     CrossRef
  • Effectiveness and safety of elbasvir/grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
    Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
    The Korean Journal of Internal Medicine.2021; 36(Suppl 1): S1.     CrossRef
  • Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
    Han Ah Lee, Young-Sun Lee, Beom Kyung Kim, Young Kul Jung, Seung Up Kim, Jun Yong Park, Ji Hoon Kim, Hyunggin An, Do Young Kim, Hyung Joon Yim, Sang Hoon Ahn, Jong Eun Yeon, Kwan Soo Byun, Kwang-Hyub Han, Soon Ho Um, Yeon Seok Seo
    Gut and Liver.2021; 15(3): 420.     CrossRef
  • Guidelines for Prevention and Treatment of Chronic Hepatitis B
    Guiqiang Wang, Zhongping Duan
    Journal of Clinical and Translational Hepatology.2021; 000(000): 000.     CrossRef
  • The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
    Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
    Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
  • Diagnosis and Management of Esophageal and Gastric Variceal Bleeding: Focused on 2019 KASL Clinical Practice Guidelines for Liver Cirrhosis
    Min Kyung Park, Yun Bin Lee
    The Korean Journal of Gastroenterology.2021; 78(3): 152.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

    Clinical and Molecular Hepatology.2020; 26(2): 83.     CrossRef
  • Ultrasonographic morphological diagnosis of chronic liver disease: 2-dimensional shear wave elastography as an add-on test
    Young Seo Cho, Woo Kyoung Jeong, Yongsoo Kim
    Ultrasonography.2020; 39(3): 272.     CrossRef
  • Toward Quantitative and Operator-independent Quasi-static Ultrasound Elastography: An Ex Vivo Feasibility Study
    Sathiyamoorthy Selladurai, Abhilash Verma, Arun K. Thittai
    Ultrasonic Imaging.2020; 42(4-5): 179.     CrossRef
  • A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus
    Min Cong, Xiaojuan Ou, Jian Huang, Jiang Long, Tong Li, Xueen Liu, Yanhong Wang, Xiaoning Wu, Jialing Zhou, Yameng Sun, Qinghua Shang, Guofeng Chen, Hui Ma, Wen Xie, Hongxin Piao, Yongping Yang, Zhiliang Gao, Xiaoyuan Xu, Zongnan Tan, Chitty Chen, Na Zeng
    OMICS: A Journal of Integrative Biology.2020; 24(7): 415.     CrossRef
  • Serum small extracellular vesicle‐derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma
    Soon Sun Kim, Geum Ok Baek, Hye Ri Ahn, Suna Sung, Chul Won Seo, Hyo Jung Cho, Suk Woo Nam, Jae Youn Cheong, Jung Woo Eun
    Molecular Oncology.2020; 14(10): 2646.     CrossRef
  • Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
    Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong
    Clinical and Molecular Hepatology.2020; 26(4): 540.     CrossRef
  • Managing liver cirrhotic complications: Overview of esophageal and gastric varices
    Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani
    Clinical and Molecular Hepatology.2020; 26(4): 444.     CrossRef
  • Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose
    Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
    Gut and Liver.2020; 14(6): 775.     CrossRef
  • The changing epidemiology of liver diseases in the Asia–Pacific region
    Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng
    Nature Reviews Gastroenterology & Hepatology.2019; 16(1): 57.     CrossRef
  • Fibrosis‐matched outcomes between chronic hepatitis B patients with drug‐induced virological response and inactive carriers
    Hye Soo Kim, Oidov Baatarkhuu, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kijun Song, Kwang‐Hyub Han, Beom Kyung Kim, Seung Up Kim
    Liver International.2019; 39(1): 81.     CrossRef
  • Towards quantitative quasi-static ultrasound elastography using a reference layer for liver imaging application: A preliminary assessment
    Sathiyamoorthy Selladurai, Arun K. Thittai
    Ultrasonics.2019; 93: 7.     CrossRef
  • Prognosis of 732 ursodeoxycholic acid‐treated patients with primary biliary cholangitis: A single center follow‐up study from China
    Sha Chen, Weijia Duan, Min Li, Shuxiang Li, Tingting Lv, Qiuju Tian, Qianyi Wang, Xiaoning Wu, Xinyan Zhao, Xiaoming Wang, Yu Wang, Yuanyuan Kong, Hong Ma, Xiaojuan Ou, Hong You, Jidong Jia
    Journal of Gastroenterology and Hepatology.2019; 34(7): 1236.     CrossRef
  • Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model
    Tatsuro Nishimura, Taro Takami, Ryo Sasaki, Yuki Aibe, Takashi Matsuda, Koichi Fujisawa, Toshihiko Matsumoto, Naoki Yamamoto, Kenji Tani, Yasuho Taura, Isao Sakaida, Matias A Avila
    PLOS ONE.2019; 14(1): e0210588.     CrossRef
  • Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology
    Dong-Hwan Jung, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Won Song, Chul-Soo Ahn, Deok-Bog Moon, Sung-Gyu Lee
    Annals of Surgery.2019; 269(3): 511.     CrossRef
  • Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis
    Haripriya Gupta, Gi Soo Youn, Sang Hak Han, Min Jea Shin, Sang Jun Yoon, Dae Hee Han, Na Young Lee, Dong Joon Kim, Soon Koo Baik, Ki Tae Suk
    Journal of Clinical Medicine.2019; 8(6): 862.     CrossRef
  • KASL clinical practice guidelines for management of chronic hepatitis B

    Clinical and Molecular Hepatology.2019; 25(2): 93.     CrossRef
  • Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN)
    Ji Hoon Park, Mi-Suk Park, So Jung Lee, Woo Kyoung Jeong, Jae Young Lee, Min Jung Park, Sung Soo Lee, Kyunghwa Han, Chung Mo Nam, Seong Ho Park, Kyoung Ho Lee
    Radiology.2019; 292(3): 638.     CrossRef
  • Current approaches to the management of patients with cirrhotic ascites
    Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev
    World Journal of Gastroenterology.2019; 25(28): 3738.     CrossRef
  • The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients
    Tae Yeob Kim, Ki Tae Suk, Soung Won Jeong, Tom Ryu, Dong Joon Kim, Soon Koo Baik, Joo Hyun Sohn, Woo Kyoung Jeong, Eunhee Choi, Jae Young Jang, Moon Young Kim
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test
    Eun Sun Jang, Kyung‐Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook‐Hyang Jeong
    Journal of Medical Virology.2019; 91(12): 2158.     CrossRef
  • Natural History and Treatment Indications of Chronic Hepatitis B
    Dong Hyun Sinn
    The Korean Journal of Gastroenterology.2019; 74(5): 245.     CrossRef
  • Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
    Mi Young Jeon, Hye Won Lee, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn
    Liver International.2018; 38(4): 676.     CrossRef
  • Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study
    Ki Tae Suk, Moon Young Kim, Soung Won Jeong, Jae Young Jang, Yoon Ok Jang, Soon Koo Baik
    Digestive Diseases and Sciences.2018; 63(1): 248.     CrossRef
  • Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes
    Tejasav Sehrawat, Anuraag Jindal, Paaras Kohli, Amit Thour, Jasbinder Kaur, Atul Sachdev, Yashdeep Gupta
    Diabetes Therapy.2018; 9(1): 243.     CrossRef
  • Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
    Joohwan Bae, Dong Hyun Sinn, Wonseok Kang, Geum‐Youn Gwak, Moon Seok Choi, Yong‐Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
    Liver International.2018; 38(8): 1442.     CrossRef
  • Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA
    Weijia Duan, Xiaojuan Ou, Xiaoming Wang, Yu Wang, Xinyan Zhao, Qianyi Wang, Xiaoning Wu, Wei Zhang, Hong Ma, Hong You, Jidong Jia
    Revista Española de Enfermedades Digestivas.2018;[Epub]     CrossRef
  • Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D
    Eun Sun Jang, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Woo Jin Chung, In Hee Kim, Byung Seok Lee, Sook-Hyang Jeong
    Gut and Liver.2018; 12(4): 440.     CrossRef
  • Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis
    Sung-Eun Kim, Ji Won Park, Mo-Jong Kim, Byungki Jang, Yong-Chul Jeon, Hee-Jun Kim, Akihito Ishigami, Hyoung Su Kim, Ki Tae Suk, Dong Joon Kim, Choong Kee Park, Eun-Kyoung Choi, Myoung-Kuk Jang, Leo A. van Grunsven
    PLOS ONE.2018; 13(8): e0201744.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

    Clinical and Molecular Hepatology.2018; 24(3): 230.     CrossRef
  • 2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines for Ascites and Related Complications: What Has Been Changed from the 2011 KASL Clinical Practice Guidelines?
    Yeon Seok Seo
    The Korean Journal of Gastroenterology.2018; 72(4): 179.     CrossRef
  • Iron metabolism disorders in patients with hepatitis B-related liver diseases
    Yan-Hang Gao, Jing-Yun Wang, Pei-Yan Liu, Jing Sun, Xiao-Mei Wang, Rui-Hong Wu, Xiu-Ting He, Zheng-Kun Tu, Chun-Guang Wang, Hong-Qin Xu, Jun-Qi Niu
    World Journal of Clinical Cases.2018; 6(13): 600.     CrossRef
  • Investigation on outcomes and bacterial distributions of liver cirrhosis patients with gram-negative bacterial bloodstream infection
    Yangxin Xie, Bo Tu, Xin Zhang, Jingfeng Bi, Lei Shi, Peng Zhao, Weiwei Chen, Suxia Liu, Dongping Xu, Enqiang Qin
    Oncotarget.2018; 9(3): 3980.     CrossRef
  • Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer
    Tae Hoon Ha, Byeong Gwan Kim, Donghyong Jeong, Sohee Oh, Won Kim, Yong Jin Jung, Dong Won Ahn, Ji Bong Jeong, Ji Won Kim, Kook Lae Lee, Seong-Joon Koh
    Digestive Diseases and Sciences.2017; 62(1): 273.     CrossRef
  • Comparison of clinical characteristics and outcomes of spontaneous bacterial peritonitis and culture negative neutrocytic ascites
    Sun Hee Na, Eun Jung Kim, Eun Young Nam, Kyoung-Ho Song, Pyoeng Gyun Choe, Wan Beom Park, Ji Hwan Bang, Eu Suk Kim, Sang Won Park, Hong Bin Kim, Myoung-don Oh, Nam Joong Kim
    Scandinavian Journal of Gastroenterology.2017; 52(2): 199.     CrossRef
  • Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis
    Eui Joo Kim, Jong Eun Yeon, Oh Sang Kwon, Heon Nam Lee, Seung Kak Shin, Seong Hee Kang, Kwan Soo Byun, Jeong Han Kim, So Young Kwon, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim
    Digestive Diseases and Sciences.2017; 62(3): 808.     CrossRef
  • Clinical Features of Spontaneous Bacterial Peritonitis: A 10-year Experience from a Single Center
    Ha Young Na, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung-chul Yoo
    The Korean Journal of Gastroenterology.2017; 69(2): 129.     CrossRef
  • Do We Need to Change the Treatment Strategy for Spontaneous Bacterial Peritonitis in Patients with Advanced Cirrhosis?
    Chang Wook Kim
    The Korean Journal of Gastroenterology.2017; 69(2): 93.     CrossRef
  • Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial
    Ji Hoon Park, Mi-Suk Park, So Jung Lee, Woo Kyoung Jeong, Jae Young Lee, Min Jung Park, Kyunghwa Han, Chung Mo Nam, Seong Ho Park, Kyoung Ho Lee
    BMC Cancer.2017;[Epub]     CrossRef
  • Prognostic effect of transarterial chemoembolization–induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma
    Woo‐Hyoung Kang, Shin Hwang, Gi‐Won Song, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Dong‐Hwan Jung, Gil‐Chun Park, Sung‐Gyu Lee
    Liver Transplantation.2017; 23(6): 781.     CrossRef
  • Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era
    Eun Sun Jang, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Woo Jin Chung, In Hee Kim, Byung Seok Lee, Sook-Hyang Jeong
    Gut and Liver.2017; 11(4): 543.     CrossRef
  • Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues
    Dong Joon Kim, Moon Seok Choi
    Clinical and Molecular Hepatology.2017; 23(2): 115.     CrossRef
  • 3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy
    Chang Hun Lee, In Hee Kim, Jin Chang Moon, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae Ghon Kim, Jae Do Yang, Hee Chul Yu
    World Journal of Gastroenterology.2017; 23(2): 297.     CrossRef
  • Liver cirrhosis caused by chronic Budd–Chiari syndrome
    Mengjie Lin, Feng Zhang, Yi Wang, Bin Zhang, Wei Zhang, Xiaoping Zou, Ming Zhang, Yuzheng Zhuge
    Medicine.2017; 96(34): e7425.     CrossRef
  • Hospice and Palliative Care in End Stage Liver Disease
    Moon Young Kim
    The Korean Journal of Hospice and Palliative Care.2017; 20(3): 167.     CrossRef
  • Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B
    Wei Zhang, Xiaoming Wang, Yu Wang, Xinyan Zhao, Weijia Duan, Qianyi Wang, Xiaoning Wu, Yuanyuan Kong, Hong Ma, Hong You, Xiaojuan Ou, Jidong Jia
    Medicine.2017; 96(44): e8454.     CrossRef
  • Useful Endoscopic Ultrasonography Parameters and a Predictive Model for the Recurrence of Esophageal Varices and Bleeding after Variceal Ligation
    Soung Won Jeong, Hye Soo Kim, Sang Gyune Kim, Jeong-Ju Yoo, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Ji Sung Lee, Young Seok Kim, Boo Sung Kim
    Gut and Liver.2017; 11(6): 843.     CrossRef
  • FATORES PROGNÓSTICOS E MORTALIDADE EM PACIENTES CIRRÓTICOS QUE FORAM INTERNADOS COM HEMORRAGIA DIGESTIVA ALTA VARICOSA EM UM HOSPITAL PÚBLICO
    Haroldo Luiz Jordelino da Luz, Caroline de Medeiros Linhares, Luana Fanha Souto, Bruna Luiza Zonta Ximenes Canfield, Ariane Badotti
    Arquivos Catarinenses de Medicina.2017; 46(1): 97.     CrossRef
  • Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis
    Tae Yeob Kim, Jae Gon Lee, Joo Hyun Sohn, Ji Yeoun Kim, Sun Min Kim, Jinoo Kim, Woo Kyoung Jeong
    Yonsei Medical Journal.2016; 57(1): 138.     CrossRef
  • The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
    Sun Young Yim, Yeon Seok Seo, Chang Ho Jung, Tae Hyung Kim, Jae Min Lee, Eun Sun Kim, Bora Keum, Young Kul Jong, Hyunggin An, Ji Hoon Kim, Hyung Joon Yim, Dong Sik Kim, Yoon Tae Jeen, Jong Eun Yeon, Hong Sik Lee, Hoon Jai Chun, Kwan Soo Byun, Soon Ho Um,
    Liver International.2016; 36(3): 445.     CrossRef
  • Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma
    Tae‐Yong Ha, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Gi‐Young Ko, Dong II Gwon, Chul‐Soo Ahn, Deok‐Bog Moon, Gi‐Won Song, Dong‐Hwan Jung, Han Chu Lee, Young‐Suk Lim, Kang Mo Kim, Ju Hyun Shim, Jeong‐Heon Choi, Sung‐Gyu Lee
    World Journal of Surgery.2016; 40(5): 1200.     CrossRef
  • Proton Pump Inhibitor Therapy Is Associated With Reduction of Early Bleeding Risk After Prophylactic Endoscopic Variceal Band Ligation
    Seong Hee Kang, Hyung Joon Yim, Seung Young Kim, Sang Jun Suh, Jong Jin Hyun, Sung Woo Jung, Young Kul Jung, Ja Seol Koo, Sang Woo Lee
    Medicine.2016; 95(8): e2903.     CrossRef
  • Variceal Bleeding from Anastomosis Site after Total Gastrectomy with Esophagojejunostomy
    Jung Woong Seo, Jeong Han Kim
    The Korean Journal of Gastroenterology.2016; 67(6): 341.     CrossRef
  • Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
    Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
    Digestive Diseases and Sciences.2016; 61(11): 3354.     CrossRef
  • Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
    Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn
    Clinical Gastroenterology and Hepatology.2016; 14(11): 1647.     CrossRef
  • Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease
    Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee
    Gut and Liver.2016; 10(5): 818.     CrossRef
  • Transplantation with autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial
    Ki Tae Suk, Jung‐Hwan Yoon, Moon Young Kim, Chang Wook Kim, Ja Kyung Kim, Hana Park, Seong Gyu Hwang, Dong Joon Kim, Byung Seok Lee, Sae Hwan Lee, Hong Soo Kim, Jae Young Jang, Chang‐Hyeong Lee, Byung Seok Kim, Yoon Ok Jang, Mee Yon Cho, Eun Sun Jung, Yon
    Hepatology.2016; 64(6): 2185.     CrossRef
  • Usefulness of Ultrasonographic Scoring System in Diagnosis of Alcoholic Cirrhosis
    Kyoung Min Moon, Soon Koo Baik
    Clinical Ultrasound.2016; 1(2): 92.     CrossRef
  • Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition
    Tae Yeob Kim, Do Seon Song, Hee Yeon Kim, Dong Hyun Sinn, Eileen L. Yoon, Chang Wook Kim, Young Kul Jung, Ki Tae Suk, Sang Soo Lee, Chang Hyeong Lee, Tae Hun Kim, Jeong Han Kim, Won Hyeok Choe, Hyung Joon Yim, Sung Eun Kim, Soon Koo Baik, Byung Seok Lee,
    PLOS ONE.2016; 11(1): e0146745.     CrossRef
  • Clinical features of acute hepatitis E super-infections on chronic hepatitis B
    Chong Chen, Shu-Ye Zhang, Dan-Dan Zhang, Xin-Yan Li, Yu-Ling Zhang, Wei-Xia Li, Jing-Jing Yan, Min Wang, Jing-Na Xun, Chuan Lu, Yun Ling, Yu-Xian Huang, Liang Chen
    World Journal of Gastroenterology.2016; 22(47): 10388.     CrossRef
  • Long-Term Suppression of Viral Replication in Chronic Hepatitis B: Outcomes and Future Directions
    Jae-Jun Shim
    Gut and Liver.2015;[Epub]     CrossRef
  • Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma
    Jeong-Heon Choi, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Young Ko, Dong Il Gwon, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
    Korean Journal of Hepato-Biliary-Pancreatic Surgery.2015; 19(2): 59.     CrossRef
  • The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
    In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    Clinical and Molecular Hepatology.2015; 21(1): 32.     CrossRef
  • The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients
    Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
    Journal of Gastrointestinal Surgery.2015; 19(7): 1281.     CrossRef
  • Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
    Jin Chang Moon, Seong Hun Kim, In Hee Kim, Chang Hun Lee, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae-Ghon Kim
    Gut and Liver.2015;[Epub]     CrossRef
  • Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin
    Chansoo Moon, Kyu Sik Jung, Do Young Kim, Oidov Baatarkhuu, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Sang Hoon Ahn, Kwang-Hyub Han
    Digestive Diseases and Sciences.2015; 60(2): 573.     CrossRef
  • Improvement of liver function and non‐invasive fibrosis markers in hepatitis B virus‐associated cirrhosis: 2 years of entecavir treatment
    Seung Kak Shin, Jeong Han Kim, Hyeonsu Park, Oh Sang Kwon, Hyun Jung Lee, Jong Eun Yeon, Kwan Soo Byun, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim
    Journal of Gastroenterology and Hepatology.2015; 30(12): 1775.     CrossRef
  • Evaluation of portal hypertension by real‐time shear wave elastography in cirrhotic patients
    Tae Yeob Kim, Woo Kyoung Jeong, Joo Hyun Sohn, Jinoo Kim, Min Yeong Kim, Yongsoo Kim
    Liver International.2015; 35(11): 2416.     CrossRef
  • Liver Stiffness Measurement, Better than APRI, Fibroindex, Fib-4, and NBI Gastroscopy, Predicts Portal Hypertension in Patients with Cirrhosis
    Wei Zhang, Liqiong Wang, Lei Wang, Gang Li, Aoshuang Huang, Ping Yin, Zhenhua Yang, Changquan Ling, Lingtai Wang
    Cell Biochemistry and Biophysics.2015; 71(2): 865.     CrossRef
  • What we know about paracentesis induced circulatory dysfunction?
    Jeong Han Kim
    Clinical and Molecular Hepatology.2015; 21(4): 349.     CrossRef
  • Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
    Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong
    Clinical and Molecular Hepatology.2014; 20(4): 347.     CrossRef
  • Prevention of Variceal Rebleeding According to the Dose of Propranolol
    Jae Young Jang, Woong Cheul Lee
    Korean Journal of Medicine.2014; 86(1): 30.     CrossRef
  • Sarcopenia as a Useful Predictor for Long-Term Mortality in Cirrhotic Patients with Ascites
    Tae Yeob Kim, Min Yeong Kim, Joo Hyun Sohn, Sun Min Kim, Jeong Ah Ryu, Sanghyeok Lim, Youngsoo Kim
    Journal of Korean Medical Science.2014; 29(9): 1253.     CrossRef
  • Clinically Severe Portal Hypertension: Role of Multi-detector Row CT Features in Diagnosis
    Ji Young Lee, Tae Yeob Kim, Woo Kyoung Jeong, Yongsoo Kim, Jinoo Kim, Kyoung Won Kim, Young Hwan Kim, Joo Hyun Sohn
    Digestive Diseases and Sciences.2014; 59(9): 2333.     CrossRef
  • Cyanoacrylate Injection Compared with Band Ligation for Acute Gastric Variceal Hemorrhage: A Meta-Analysis of Randomized Controlled Trials and Observational Studies
    Xiaohua Ye, Jiaping Huai, Yanping Chen
    Gastroenterology Research and Practice.2014; 2014: 1.     CrossRef
  • Clinical Features of Non-alcoholic Fatty Liver Disease in Cryptogenic Hepatocellular Carcinoma
    Min Young Rim, Oh Sang Kwon, Minsu Ha, Ju Seung Kim, Kwang Il Ko, Dong Kyu Kim, Pil Kyu Jang, Jung Yoon Han, Pyung Hwa Park, Young Kul Jung, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
    The Korean Journal of Gastroenterology.2014; 63(5): 292.     CrossRef
  • Histological improvement following administration of autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study
    Yoon Ok Jang, Young Ju Kim, Soon Koo Baik, Moon Young Kim, Young Woo Eom, Mee Yon Cho, Hong Jun Park, So Yeon Park, Bo Ra Kim, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Eun Hee Choi, Yong Man Kim
    Liver International.2014; 34(1): 33.     CrossRef
  • Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
    Won Ki Hong, Kwang Yong Shim, Soon Koo Baik, Moon Young Kim, Mee Yon Cho, Yoon Ok Jang, Young Shik Park, Jin Han, Gaeun Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Sang Ok Kwon
    Journal of Korean Medical Science.2014; 29(3): 392.     CrossRef
  • Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker
    Tae Seop Lim, Beom Kyung Kim, Jong Wook Lee, Young Ki Lee, Sooyun Chang, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Jun Yong Park, Charles C. Caldwell
    PLoS ONE.2014; 9(1): e86884.     CrossRef
  • Alcoholic liver disease: Treatment
    Ki Tae Suk
    World Journal of Gastroenterology.2014; 20(36): 12934.     CrossRef
  • Association of polymorphism in MicroRNA 219‐1 with clearance of hepatitis B virus infection
    Jae Youn Cheong, Hyoung Doo Shin, Yoon Jun Kim, Sung Won Cho
    Journal of Medical Virology.2013; 85(5): 808.     CrossRef
  • Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection
    Chang Bum Bae, Soon Sun Kim, Seun Joo Ahn, Hyo Jung Cho, Sei Rhan Kim, Sun Young Park, Ga Won Song, Dong Joon Kim, Seong Gyu Hwang, Jin Mo Yang, Young Bae Kim, Young Nyun Park, Sung Jae Shin, Sung Won Cho, Jae Youn Cheong
    Journal of Clinical Virology.2013; 58(4): 641.     CrossRef
  • The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data
    Won Ki Hong, Moon Young Kim, Soon Koo Baik, Seung Yong Shin, Jung Min Kim, Yong Seok Kang, Yoo Li Lim, Young Ju Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Hyoun A Kim, Hye Won Kang, Sang Ok Kwon
    Clinical and Molecular Hepatology.2013; 19(4): 370.     CrossRef
  • Prevention and Management of Variceal Hemorrhage
    Dong Hyun Kim, Jun Yong Park
    International Journal of Hepatology.2013; 2013: 1.     CrossRef
  • Comparison of Endoscopic Variceal Ligation and Endoscopic Variceal Obliteration in Patients with GOV1 Bleeding
    Hyoung Ju Hong, Chung Hwan Jun, Du Hyeon Lee, Eun Ae Cho, Seon Young Park, Sung Bum Cho, Chang Hwan Park, Young Eun Joo, HyunSoo Kim, Sung Kyu Choi, Jong Sun Rew
    Chonnam Medical Journal.2013; 49(1): 14.     CrossRef
  • The Korean National Liver Cancer Surveillance Program: Experience of a Single Healthcare Center in 2011
    Jae-Jun Shim, Hyun Jin Park, Jung-Wook Kim, Eun Jung Hwang, Chang Kyun Lee, Jae Young Jang, Seong Jin Park, Hyun Rim Choi, Byung-Ho Kim
    Korean Journal of Medicine.2013; 84(5): 672.     CrossRef
  • Spontaneous Healing of Gastric Perforation after Endoscopic Ligation for Gastric Varices
    Jung Ho Kim, Hong Dae Ahn, Kwang An Kwon, Yoon Jae Kim, Jun-Won Chung, Dong Kyun Park, Ju Hyun Kim
    Journal of Korean Medical Science.2013; 28(4): 624.     CrossRef
  • A Case of Spontaneous Bacterial Peritonitis Caused byListeria monocytogenes
    Byung Sihk Kim, Tae Yeob Kim, Ji Yeoun Kim, Kyo Sang Yoo, Yong Chul Jeon, Dong Soo Han, Joo Hyun Sohn, Jieun Kim
    The Korean Journal of Gastroenterology.2013; 62(3): 179.     CrossRef
  • Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study
    Se Young Jang, Go Heun Kim, Soo Young Park, Chang Min Cho, Won Young Tak, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Jae Myeong Lee, Sang Gyune Kim, Dae Yong Kim, Young Seok Kim, Se-Ok Lee, Yang Won Min, Joon Hyeok Lee, Seung Woon Paik, Byung Chul Yoo,
    Clinical and Molecular Hepatology.2012; 18(4): 368.     CrossRef
  • Spontaneous Bacterial Peritonitis with Sepsis Caused byEnterococcus hirae
    Jong Seop Sim, Hyoung Su Kim, Ki Jong Oh, Myung Soo Park, Eun Ju Jung, Youn Joo Jung, Dae Gil Kang, Seung In Seo, Won Jin Kim, Myoung Kuk Jang
    Journal of Korean Medical Science.2012; 27(12): 1598.     CrossRef
  • 65,535 View
  • 190 Download
  • Crossref
Case Report
Transcatheter coil embolization of the inferior epigastric artery in a huge abdominal wall hematoma caused by paracentesis in a patient with liver cirrhosis
Yun Ji Park, Sang Yeon Lee, Seong Hun Kim, In Hee Kim, Sang Wook Kim, Seung Ok Lee
Korean J Hepatol 2011;17(3):233-237.
Published online September 30, 2011
DOI: https://doi.org/10.3350/kjhep.2011.17.3.233

Therapeutic paracentesis is considered to be a relatively safe procedure and is performed commonly for the control of massive ascites in patients with liver cirrhosis. The commonest puncture site, approximately 4 or 5 cm medial of left anterior superior iliac spine, can be located across the route of the inferior epigastric artery, which is one of the sites of potential massive bleeding. In a 46-year-old woman with liver cirrhosis and refractory ascites, a huge abdominal wall hematoma developed after therapeutic paracentesis. The patient was not stabilized by conservative treatment, and inferior epigastric artery injury was confirmed on angiography. Angiographic coil embolization of the inferior epigastric artery was conducted, after which the bleeding ceased and the hematoma stopped growing. This case indicates that physicians performing paracentesis should be aware of the possibility of inferior epigastric artery injury and consider early angiographic coil embolization when a life-threatening abdominal wall hematoma develops.

Citations

Citations to this article as recorded by  Crossref logo
  • Abdominal wall hematoma related to subcutaneous low-molecular-weight heparin injection following coronary intervention therapy: case presentation
    Xiao-Hua LIU, Yi-Zhou XU
    Journal of Geriatric Cardiology.2025; 22(1): 214.     CrossRef
  • Successful Transcatheter Arterial Embolization of Abdominal Wall Hematoma from the Left Deep Circumflex Iliac Artery after Abdominal Paracentesis in a Patient with Liver Cirrhosis: Case Report and Literature Review
    Young Eun Seo, Chae June Lim, Jae Woong Lim, Je Seong Kim, Hyung Hoon Oh, Keon Young Ma, Ga Ram You, Chan Mook Im, Byung Chan Lee, Young Eun Joo
    The Korean Journal of Gastroenterology.2024; 83(4): 167.     CrossRef
  • Lights and Shadows of Paracentesis: Is an Ultrasound Guided Approach Enough to Prevent Bleeding Complications?
    Marta Patturelli, Luca Pignata, Pietro Venetucci, Maria Guarino
    Livers.2023; 3(1): 54.     CrossRef
  • Superselective Transcatheter Arterial Embolization of iatrogenic inferior epigastric artery after paracentesis: unusual manifestation of hemoperitoneum
    Tulio Fabiano De Oliveira Leite
    Journal of Hazardous Materials.2020; : 123578.     CrossRef
  • Superselective transcatheter arterial embolization of iatrogenic inferior epigastric artery after paracentesis: Unusual manifestation of hemoperitoneum
    Tulio Fabiano de Oliveira Leite
    International Journal of Surgery Case Reports.2020; 74: 32.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

    Clinical and Molecular Hepatology.2018; 24(3): 230.     CrossRef
  • Emergency Endovascular Hemostatic Technique Using N-butyl Cyanoacrylate for Retroperitoneal Hematoma Caused by Inferior Epigastric Artery Injury after Undergoing Catheter Ablation for Atrial Fibrillation: A Case Report
    Junya Tsurukiri, Eitaro Okumura, Hidefumi Sano, Mariko Moriya, Hiroshi Yamanaka, Keisuke Watanabe, Akira Hoshiai
    Journal of Neuroendovascular Therapy.2017; 11(12): 608.     CrossRef
  • Ultrasound-guided thrombin injection for treatment of superficial traumatic pseudoaneurysms and associated expanding hematomas: experience in five patients
    Sri Hari Sundararajan, Phillip Murillo, Adam Khan, Vyacheslav Gendel, Christopher Gribbin, Sudipta Roychowdhury, John Nosher
    Journal of Trauma Management & Outcomes.2016;[Epub]     CrossRef
  • Successful Coil Embolization of Circumflex Iliac Artery Pseudoaneurysms Following Paracentesis
    Ryan W. Day, Eric A. Huettl, Sailendra G. Naidu, William G. Eversman, David D. Douglas, Mark E. O’Donnell
    Vascular and Endovascular Surgery.2014; 48(3): 262.     CrossRef
  • A fatal complication of ultrasound‐guided abdominal paracentesis
    Matthew Seidler, Karl Sayegh, Anne Roy, Benoît Mesurolle
    Journal of Clinical Ultrasound.2013; 41(7): 457.     CrossRef
  • 9,824 View
  • 63 Download
  • Crossref